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cessation; Table 2 shows the time between discontinuation of
clopidogrel and SET. Early (less than three months with SES and
six months with PES) discontinuation of dual antiplatelet therapy
was required in seven patients, one of whom developed SET,
whereas late discontinuation was observed in eight patients, three
of whom had SET. Two patients also stopped clopidogrel early,
and both developed SET.
Stent thrombosis was always associated with major adverse
events: three patients died (43%) and four patients developed an
extensive STEMI (57%). Finally, both DES designs had similar
incidence of SET (1.9% with SES and 1.5% with PES).
With current antiplatelet therapy, stent thrombosis after coro-
nary bare stent therapy is a rare event after hospital discharge; in
fact, in the ERACI II study stent arm, patients were under
ticlopidine during one month and after hospital discharge, and no
patient had SET during the first year of follow-up (10). Further-
more, in the present study, among patients simultaneously treated
with DES and bare stent, CST was present only at the place of
DES implantation. The ERACI III study data suggested that
SET with DES is unexpected and can occur either early after
hospital discharge or very late in the follow-up phase, when many
patients have discontinued antiplatelet therapy. The clinical im-
plications of these findings suggest a potential concern with the
current widespread use of DES and show the need for larger
controlled studies.
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Noncalcified and Calcified Coronary Plaque Detection by Contrast-Enhanced
Multi-Detector Computed Tomography: A Study of Interobserver Agreement
To the Editor: Contrast-enhanced multi-detector computed to-
mography (MDCT) coronary angiography permits reliable visual-
ization of coronary arteries. Recent studies showed a high sensi-
tivity and specificity of 16-slice MDCT for the detection of
hemodynamically significant coronary stenosis (1,2). In addition to
luminal narrowing, it was early recognized that MDCT also
visualizes the diseased coronary arterial wall (3). Two recent
studies with 16-slice MDCT showed sensitivity of 75% and 82%
and specificity of 88% and 92% to detect coronary plaque using
intravascular ultrasound as the standard of reference (4,5). The
goal of our study was to establish the interobserver reproducibility
of coronary plaque detection by 16-slice MDCT.
We enrolled 45 consecutive patients (37 men; mean age, 56 
9 years; mean heart rate during the scan, 55  6 beats/min) who
underwent contrast-enhanced MDCT before coronary angiogra-
phy as part of a research protocol. Patients were scheduled for a
clinically indicated invasive coronary angiography. Only patients
with a heart rate 65 beats/min were included in the evaluation.
Patients with allergic reaction to iodinated contrast, atrial fibrilla-
tion, or creatinine serum level1.5 mg/ml were excluded from the
study. The institutional review boards approved the study protocol,
and patients’ written informed consents were obtained.
Examinations were performed with a 16-slice MDCT scanner
(Siemens, Forchheim, Germany; tube current, 550 mA; tube
voltage, 120 kVp; collimation, 16 0.75 mm; gantry rotation, 375
ms; contrast, 90 ml iopromide 370 mgI/ml; slice thickness, 1 mm
at 0.5-mm intervals; kernel B35f). An oral beta-blocker (atenolol
100 mg) was administered one hour before the scan to 38 (84%)
patients with a heart rate 60 beats/min. Sublingual nitroglycerin
(glycerol trinitrate 0.8 mg) was administered immediately before
the scan. Prospectively, electrocardiographically triggered tube
current modulation was applied during all examinations.
The MDCT datasets (axial, multiplanar reformatted, and
maximum-intensity projection images) were evaluated by two
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investigators. Images were initially analyzed at a predefined win-
dow and level setting (window, 700 HU; level, 200 HU). Adjust-
ments of the image display setting were performed on the
discretion of an observer if deemed necessary.
Investigators visually evaluated images for the presence of
plaque in all 17 coronary segments defined by the American
Heart Association (6). Previously defined criteria for the eval-
uation of atherosclerotic plaque in contrast-enhanced MDCT
coronary angiography were applied (Fig. 1) (4,5). Coronary
artery segments were identified in a consensus reading via side
branches. Subsequently, the investigators separately and inde-
pendently analyzed each coronary segment. They graded the
image quality for every segment as excellent (no artifacts), good
(minimal motion artifacts and/or increased image noise, but
evaluable), or nonevaluable. For each coronary segment with
excellent or good image quality, the investigators then decided
whether calcified plaque, noncalcified plaque, both, or neither
were present in MDCT. Kappa statistic was calculated to
determine interobserver agreement.
A total of 735 coronary segments were identified. Fifty coronary
segments (46 side branches, 2 mid segments, and 2 distal seg-
ments) were deemed nonevaluable by one or both observers.
Segments were excluded because of small vessel caliber (n  45),
motion artifacts (n  4), or incomplete visualization of the
posterior descending coronary artery (n  1).
Coronary plaque was detected in 237 of 685 (34.6%) segments
by observer #1 and in 238 of 685 (34.7%) segments by observer #2.
Calcified plaque was detected in 158 of 685 (23.1%) segments both
by observer #1 and observer #2. Noncalcified plaque was detected
in 207 of 685 (30.2%) segments by observer #1 and in 209 of 685
(30.5%) segments by observer #2.
In the segment-based analysis, interobserver agreement was very
good for the detection of any coronary plaque (93.1% agreement,
  0.85), calcified plaque (97.7%,   0.93), and noncalcified
plaque (92.4%,   0.82). Similar results were observed in the per
vessel and per patient analysis (Table 1).
Interobserver agreement for plaque detection in the proximal
coronary segments (proximal right, left main, proximal left
anterior descending, and proximal left circumflex coronary
arteries) and distal coronary segments (all other segments)
was similar: any coronary plaque (91.7%,   0.83, vs. 93.7%,
  0.84), calcified plaque (96.1%,   0.92, vs. 98.2%,  
0.94), and noncalcified plaque (91.7%,   0.83, vs. 92.7%,  
0.79).
The potential value of noninvasive detection, quantification,
and characterization of coronary plaque for risk stratification and
disease progression monitoring is currently being explored. For
these applications, MDCT assessment of coronary plaque would
need to be consistent among different observers.
We found very high interobserver reproducibility for the detec-
tion of coronary plaque by MDCT. Using four-slice MDCT,
Leber et al. (7) reported an interobserver agreement of 79%, 88%,
and 70% for the detection of any plaque, calcified plaque, and
noncalcified plaque. In our study, corresponding results were 93%,
98%, and 92%. Good agreement was found for both calcified and
noncalcified plaque, and could be maintained in both proximal and
distal branches.
Limitations of the study include the study population that was
pre-selected with stringent exclusion criteria. Also, scans were
performed and read by very experienced investigators. Results may
therefore not be generalized to less experienced centers and a
broader range of patients. The segmental analysis used in the
present study is prone to overestimate the diagnostic performance
of MDCT. However, it provides the most reliable method for the
comparison of readings of two independent observers.
In conclusion, very good interobserver agreement was shown for
the detection of both calcified and noncalcified coronary plaque by
16-slice MDCT.
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Figure 1. Maximum-intensity projection images and corresponding cross sections (multiplanar reformatted image) showing coronary plaque (arrows): A
and B, noncalcified plaque; C and D, calcified plaque embedded within a noncalcified plaque; E and F, calcified plaque.
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Improved Atrial Mechanical Efficiency During Alternate- and Multiple-Site Atrial Pacing
Compared With Conventional Right Atrial Appendage Pacing:
Implications for Selective Site Pacing to Prevent Atrial Fibrillation
To the Editor: Alternate- and multiple-site atrial pacing (AP)
have been proposed as methods to prevent atrial fibrillation
(AF) (1,2). However, changes in atrial activation by alternate-
or multiple-site(s) AP might adversely affect atrial mechanical
function and cardiac performance via atrioventricular (AV)
mechanical coupling, especially during rapid atrial overdrive
pacing. The aim of this study was to investigate the effect of
alternate single- and dual-site AP during atrial overdrive pacing
on right atrial (RA) mechanical function and global cardiac
performance.
The study population included 12 patients without structural
heart disease (6 men, mean age: 43  14 years) after successful
radiofrequency catheter ablation of paroxysmal supraventricular
tachycardia. The study protocol was approved by our institu-
tional research board. A quadripolar electrode catheter and a
decapolar catheter were positioned in the RA appendage (RAA)
or at high intra-atrial septum (IAS) and in coronary sinus,
respectively, for pacing of RAA, IAS, coronary sinus ostium
(CSO), and distal coronary sinus (DCS). An additional elec-
trode catheter was positioned at right ventricular apex for
ventricular pacing. Atrial volume and pressure were estimated
using a 7-F custom-designed five-electrode combination
pressure-conductance catheter (Millar Instruments, Houston,
Texas) positioned within the RA as described previously (3,4).
A fluid-filled catheter in the femoral artery was used to measure
arterial pulse pressure (PP) as an index of global cardiac
performance.
Before recording hemodynamic variables, at least 3 min of
stable continuous capture at pacing site (at 3 threshold
output with pulse duration of 2 ms) was performed to achieve
steady-state conditions. Then RA pressure, RA conductance,
and PP were measured during AV pacing from RAA, IAS,
DCS, RAA  CSO, and RAA  DCS, respectively, at AV
intervals of 0, 50, 100, and 150 ms using drive cycle lengths of
350 and 500 ms in random order. Intravenous 0.9% saline
infusion at a constant rate of 100 ml/h was administered
throughout the procedure to maintain ventricular preload and
blood resistivity.
The RA pump and reservoir function were determined by
using pressure-volume plane analysis, assuming that that mea-
sured conductance was proportionate to chamber volume (3,4).
The “A” loop area and “V” loop area as quantified via planimetry
represent the active work performed by the atrium during atrial
contraction and the extent of atrial filling during ventricular
Table 1. Interobserver Coronary Plaque Detection Agreement Between Observer 1
and Observer 2
Coronary
Artery n
Any Plaque Calcified Plaque Noncalcified Plaque
Agreement
(%) Kappa
Agreement
(%) Kappa
Agreement
(%) Kappa
LM 45 93.3 0.87 100 1.00 93.3 0.87
LAD 45 97.8 0.84 100 1.00 95.6 0.89
LCX 45 86.7 0.74 93.3 0.85 82.2 0.64
RCA 45 95.6 0.88 95.6 0.91 95.6 0.88
Per segment 685 93.1 0.85 97.7 0.93 92.4 0.82
Per artery 180 93.3 0.86 97.2 0.94 91.7 0.83
Per patient 45 95.6 0.85 95.6 0.89 97.8 0.93
LAD  left anterior descending coronary artery; LCX  left circumflex coronary artery; LM  left main coronary artery; RCA
 right coronary artery.
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